|
|
||||||||
a Departments of Cardiovascular, Anesthesia, and Intensive Care, ASO Santa Croce e Carle, Via Michele Coppino n. 26, Cuneo, 12100 Italy
b Department of Cardiothoracic and Vascular Anesthesia, and Intensive Care, IRCCS Policlinico S. Donato, Via R. Morandi n. 30, San Donato Milanese, 20097 Italy
(Email: barzaghi.n@ospedale.cuneo.it; cardioanestesia@virgilio.it).
| The first 20% of the full text of this article appears below. |
To the Editor:
In a recent article, Koster and colleagues [1] reported a higher than expected frequency of heparin-induced thrombocytopenia (HIT) in patients with ventricular assist devices (VADs) who were receiving anticoagulation with unfractionated heparin. Furthermore, mortality in patients who experienced HIT after VAD implantation was considerably higher, suggesting a strong relationship between HIT occurrence and outcome. HIT was diagnosed as thrombocytopenia associated with detection of antibodies against the heparin-PF4 complexes.
"When is HIT really HIT?" is an editorial by Warkentin and Crowther [2
Related Article
Ann. Thorac. Surg. 2008 85: 361.
This article has been cited by other articles:
![]() |
T. E. Warkentin, M. A. Crowther, and A. Koster Reply Ann. Thorac. Surg., January 1, 2008; 85(1): 361 - 361. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |